Comparable monthly disclosures
Institutional Activity
Where disclosed mutual fund positions are increasing, reducing, opening or closing.
Portfolio increases
Aug 2024 · Ranked across companies with at least 10 comparable portfolios
| Company | Portfolio increases | Comparable change | Portfolios increasing | Portfolios reducing | Comparable portfolios |
|---|---|---|---|---|---|
| Navin Fluorine International Limited NAVINFLUOR | 15 30.6% of comparable | +0.04 Cr | 15 | 3 | 49 |
| Crisil Limited CRISIL | 15 53.6% of comparable | +4,914 | 15 | 6 | 28 |
| KPIT Technologies Limited KPITTECH | 15 30.6% of comparable | -62,070 | 15 | 6 | 49 |
| Exide Industries Limited EXIDEIND | 15 36.6% of comparable | +0.02 Cr | 15 | 6 | 41 |
| Syngene International Limited SYNGENE | 15 41.7% of comparable | +0.01 Cr | 15 | 6 | 36 |
| Dr. Lal Path Labs Ltd. LALPATHLAB | 15 45.5% of comparable | -0.02 Cr | 15 | 8 | 33 |
| Aditya Birla Fashion and Retail Limited ABFRL | 15 34.1% of comparable | -0.46 Cr | 15 | 9 | 44 |
| Astral Limited ASTRAL | 15 35.7% of comparable | -0.06 Cr | 15 | 10 | 42 |
| L&T Finance Limited LTF | 15 35.7% of comparable | -0.08 Cr | 15 | 10 | 42 |
| Gland Pharma Limited GLAND | 15 30.6% of comparable | -0.06 Cr | 15 | 11 | 49 |
| FSN E-Commerce Ventures Limited NYKAA | 15 24.6% of comparable | +1.50 Cr | 15 | 13 | 61 |
| Steel Authority of India Limited SAIL | 15 29.4% of comparable | -1.41 Cr | 15 | 14 | 51 |
| Ashok Leyland Limited ASHOKLEY | 15 28.3% of comparable | -0.32 Cr | 15 | 15 | 53 |
| Balkrishna Industries Limited BALKRISIND | 15 26.8% of comparable | -0.04 Cr | 15 | 18 | 56 |
| Castrol India Limited CASTROLIND | 14 60.9% of comparable | +0.03 Cr | 14 | 1 | 23 |
| Global Health Limited MEDANTA | 14 42.4% of comparable | +0.05 Cr | 14 | 3 | 33 |
| Mahanagar Gas Limited MGL | 14 56.0% of comparable | -7,543 | 14 | 4 | 25 |
| Schaeffler India Limited SCHAEFFLER | 14 21.2% of comparable | +0.02 Cr | 14 | 6 | 66 |
| Tata Elxsi Limited TATAELXSI | 14 51.9% of comparable | +0.06 Cr | 14 | 6 | 27 |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO | 14 42.4% of comparable | +0.02 Cr | 14 | 7 | 33 |
| Granules India Limited GRANULES | 14 35.9% of comparable | +0.01 Cr | 14 | 8 | 39 |
| Aditya Birla Capital Limited ABCAPITAL | 14 40.0% of comparable | +0.06 Cr | 14 | 9 | 35 |
| GUJARAT ENERGY LIMITED GUJENERGY | 14 46.7% of comparable | +0.14 Cr | 14 | 9 | 30 |
| Fortis Healthcare Limited FORTIS | 14 24.6% of comparable | +0.27 Cr | 14 | 10 | 57 |
| ACC Limited ACC | 14 24.6% of comparable | -0.08 Cr | 14 | 12 | 57 |
How to read this activity
Activity compares disclosed positions for economic portfolios observed in both relevant monthly disclosures and adjusts for externally evidenced corporate actions where available.
At least 10 comparable portfolios are required. Companies under corporate-action review are excluded. Counts are unweighted by portfolio size, and share changes are quantities rather than market values; zero counts can appear at the end of a ranking. Breadth change is the change in AMCs holding, and can also reflect reporting coverage.
Full methodology →